A Study to Validate a New Oral Fluid/Saliva Antibody Test for Novel H1N1v Influenza
Sponsored by Public Health England
About this trial
Last updated 15 years ago
Study ID
OFLU
Status
Completed
Type
Observational
Placebo
No
Accepting
6+ Years
All
Trial Timing
Ended 15 years ago
What is this trial about?
At present influenza immunity can only be reliably confirmed by a blood test. This test
is invasive for the patient. This study is intended to validate an oral fluid/saliva
antibody test for the variant Swine Influenza H1N1. If such a test were available, this
painless and non invasive test will improve direct clinical care to an individual as well
as significantly help guide future public health management of the pandemic.
What are the participation requirements?
Inclusion Criteria
- Participants of the clinical service evaluation of novel H1N1v vaccine
- First or second blood sample for the clinical service evaluation successfully collected
Exclusion Criteria
- Withdrawn from clinical service evaluation of novel H1N1v vaccine
- Second blood sample for the clinical service evaluation not collected.